Gayathri Devi, PhD, Awarded Department of Defense Breakthrough Award to Study Breast Cancer Metastasis
Gayathri Devi, PhD, Associate Professor of Surgery and Pathology, and Member of the Women’s Cancer Program at the Duke Cancer Institute, has received a Breakthrough Award from the Department of Defense Breast Cancer Research Program (CDMP-BCRP) in the amount of $1,192,441.
Duke Researchers Find Alcohol Abuse Drug Disrupts Tumor Emboli Formation in Inflammatory Breast Cancer
Study Provides New Insights Into 3D Imaging and Targeting Tumor Emboli in Patients with Inflammatory Breast Cancer
Duke researchers have found that a drug used for alcohol abuse reduces the formation of tumor emboli in inflammatory breast cancer (IBC), one of the most lethal types of breast cancer. Current barriers to the successful treatment of IBC include the presence and frequent infiltration of tumor cell clusters, termed tumor emboli, within the breast parenchyma and lymphatics.
Dr. Rachel Greenup Receives Health Policy Scholarship
Congratulations to Rachel Greenup, MD, MPH, Division of Advanced Oncologic and Gastrointestinal Surgery, for being selected as a recipient of the Health Policy Scholarship provided by the American College of Surgeons and the American Society of Breast Surgeons.
Duke Surgery Faculty Publish Comprehensive Guide on Thyroid Nodules and Cancer
According to Sanziana Roman, MD, and Julie Ann Sosa, MD, Division of Advanced Oncologic and Gastrointestinal Surgery, thyroid nodules continue to be a common problem worldwide. Though many nodules are benign, anxiety on the part of both the physician and patient can cause unnecessary interventions to take place.
Reducing Radiation Could Safely Cut Breast Cancer Treatment Costs
A shorter regimen is scientifically sound, but most women still get the longer therapy
More than half of older women with early stage breast cancer received more radiation therapy than what might be medically necessary, adding additional treatment and health care costs, according to a study led by Duke Cancer Institute researchers.
Humanism in Medicine Award Presented to Duke Surgery Faculty Member
The Leonard Tow Humanism in Medicine Award is presented annually to a Duke faculty member who embodies the characteristics recognized by the award: compassion, sensitivity, respect for patients and colleagues, and clinical excellence. Sponsored by the Arnold P. Gold Foundation, this honor recognizes faculty of the highest caliber at nearly 80 of the nation’s medical schools.
Duke Announces Postdoctoral Research Training in Surgical Oncology
The Duke University Postdoctoral Research Training in Surgical Oncology Training Grant has 3 positions available for 2-year research fellowships. Candidates must have an MD or equivalent degree and be in good standing or have completed a clinical training program that supports eligibility for certification in General Surgery, Thoracic Surgery, Urology, Head and Neck Surgery, Orthopaedic Surgery, Neurosurgery, or an ACGME-approved surgical subspecialty. Candidates must be US citizens or permanent residents.
Dr. Lisa Tolnitch Receives Humanism in Medicine Award for Exceptional Work in Breast Cancer Treatment
Each year, the American Society of Breast Surgeons and the Arnold P. Gold Foundation present the Humanism in Medicine Award to one practicing physician who provides effective, compassionate, and empathetic care to breast cancer patients. Duke Surgery would like to congratulate Lisa Tolnitch, MD, Assistant Professor, Division of Advanced Oncologic and Gastrointestinal Surgery, for being the 2017 recipient of the Humanism in Medicine Award. Dr. Tolnitch is recognized for her continued efforts to provide breast cancer treatments to underinsured and uninsured patients in North Carolina.
Dr. Oluwadamilola "Lola" Fayanju Selected as KL2 Scholar through Duke Clinical and Translational Science Institute
Congratulations to Dr. Oluwadamilola “Lola” Fayanju, Assistant Professor of Surgery, Division of Advanced Oncologic and Gastrointestinal Surgery, for being selected as a KL2 Scholar through the Duke Clinical and Translational Science Institute. The objective of the KL2 program is to train and develop young investigators using state-of-the-art clinical and translational research methods.
High-Volume Hospitals Have the Greatest Success in the Fight Against Breast Cancer
Breast cancer is the most prevalent cancer diagnosis for women in the United States, with over a quarter million new cases reported in 2016. While incidence rates have decreased in the U.S. since 2000, the treatment of breast cancer has become more varied and complex in recent years, with systemic therapy, surgery, and radiation offering diverse approaches to treatment. The success of these treatments varies from patient to patient, but a new study led by Dr. Rachel A.